Traditional value assessment and reimbursement decision-making often ignores value elements that are important to the patient or to wider society. These values and preferences are not adequately captured in traditional outcome measures, and so what is important to patients in their treatment journey is often misrepresented.
In this Masterclass, we move beyond narrow definitions of patient benefit to capture what really matters to patients.
We explore what matters to patients when considering their treatment options, including treatment acceptability, administration mode, and other treatment features. Patient preference studies identify the most critical characteristics of a treatment and examine the trade-offs that patients are willing to make between them.
OHE experts explain how credible and insightful evidence on patient preferences can be generated and discuss how they can be incorporated into Health Technology Assessment and reimbursement decision-making. They will discuss a range of critical challenges in considering patient preference studies in reimbursement decisions with a panel of international experts to understand when these studies can be more valuable to the decision process, and how their role can be strengthened.
Full details and book available here.
With its devastating and far-reaching consequences, the pandemic has made clear that health and wealth are inextricably interlinked. The rapid development and introduction of new interventions to fight COVID-19 has also demonstrated that the value of healthcare interventions go far beyond narrowly defined patient benefits.
What is the real value of a highly effective vaccine for COVID-19? What wouldn’t a society pay to rid itself of the virus?
Whilst the broader value of treatments and vaccines are acknowledged at the height of the pandemic, it is critical that in the post-pandemic recovery period, that health systems invest in interventions that create the greatest value.
The 2021 Masterclass Series will take attendees through the journey of exploring value from multiple perspectives, providing tools to identify consolidated and novel sources of value, and generate compelling evidence to demonstrate them.
Whilst value assessments are necessary to ensure that healthcare expenditure is optimal, there is also a need for a common understanding of what constitutes value, capturing what matters most to patients, society, and payers.
“Demonstrating Value: evolving with innovation” will explore this lively technical and policy debate, where the evolving and sometimes challenging nature of innovative interventions is not always matched by the value assessment paradigms applied by country decision-makers.
OHE’s 2021 Masterclass may be virtual but its excellence will be real. Join OHE experts and a faculty of international thought-leaders in this stimulating and insightful series on Demonstrating Value.
- To gain a deep-dive on theory and real-world evidence on the current debate on the value of innovative interventions to patients, healthcare systems and society, and anticipate future developments
- To discuss and understand opportunities and barriers for the incorporation of broader sources of value which matter the most to patients and society, in terms of payers and decision-makers acceptability and evidence requirements
- To understand the optimal approaches and solutions to improve patients, health systems and industry outcomes in areas of high unmet need such as rare diseases